Related Experiment Video
Updated: Feb 25, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth
Jinping Liu1,2, Alex Kruswick1, Hien Dang2
1Laboratory of Receptor Biology and Gene Expression, National Cancer Institute, 41 Library Drive, Bethesda, MD, 20892, USA.
Abstract:
Tumor growth relies on efficient DNA repair to mitigate the detrimental impact of DNA damage associated with excessive cell division. Modulating repair factor function, thus, provides a promising strategy to manipulate malignant growth. Here, we identify the ubiquitin-specific protease USP21 as a positive regulator of BRCA2, a key mediator of DNA repair by homologous recombination. USP21 interacts with, deubiquitinates and stabilizes BRCA2 to promote efficient RAD51 loading at DNA double-strand breaks. As a result, depletion of USP21 decreases homologous recombination efficiency, causes an increase in DNA damage load and impairs tumor cell survival. Importantly, BRCA2 overexpression partially restores the USP21-associated survival defect. Moreover, we show that USP21 is overexpressed in hepatocellular carcinoma, where it promotes BRCA2 stability and inversely correlates with patient survival. Together, our findings identify deubiquitination as a means to regulate BRCA2 function and point to USP21 as a potential therapeutic target in BRCA2-proficient tumors.BRCA2 is essential for the repair of DNA damage; therefore, defects in BRCA2 are associated with tumorigenesis but also with increased susceptibility to genotoxic stress. Here the authors show that USP21 regulates the ability of tumor cells to repair damaged DNA by regulating BRCA2 stability.
Insights
The ubiquitin-specific protease USP21 stabilizes BRCA2, a key DNA repair protein, thereby promoting tumor cell survival. Inhibiting USP21 may offer a new therapeutic strategy for BRCA2-proficient cancers.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Tumorigenesis is linked to DNA repair mechanisms, making them potential therapeutic targets.
- BRCA2 is crucial for homologous recombination DNA repair, and its dysregulation contributes to cancer development.
Purpose of the Study:
- To investigate the role of USP21 in regulating BRCA2 function and its impact on tumor cell survival.
- To explore USP21 as a potential therapeutic target in BRCA2-proficient tumors.
Main Methods:
- Identifying USP21 as a regulator of BRCA2 through interaction and deubiquitination assays.
- Assessing the impact of USP21 depletion on homologous recombination, DNA damage, and tumor cell survival.
- Analyzing USP21 expression in hepatocellular carcinoma and its correlation with patient survival.
Main Results:
- USP21 deubiquitinates and stabilizes BRCA2, enhancing RAD51 loading at DNA breaks.
- USP21 depletion impairs homologous recombination, increases DNA damage, and reduces tumor cell survival.
- USP21 is overexpressed in hepatocellular carcinoma, correlating with poor patient survival.
Conclusions:
- Deubiquitination by USP21 is a novel mechanism for regulating BRCA2 activity.
- USP21 represents a promising therapeutic target for BRCA2-proficient cancers, particularly hepatocellular carcinoma.
More Related Videos
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Anaphase Promoting Complex
The Intrinsic Apoptotic Pathway

